NIH-funded research R01 grant

Improving Nutritional Support for Anorexia Nervosa

Official title: Multi-center Randomized Controlled Trial of Refeeding an Anorexia Nervosa

Funded at University of California, San Francisco · NIH-11061401 · Data updated 2026-11-12

This research compares different ways to provide nutrition to young people hospitalized for anorexia nervosa, aiming to help them recover faster and stay well.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startJuly 13, 2015
Project endMarch 31, 2027
Funding year2025
Award (this year)$664,130
NIH project number5R01HD082166-10
Project IDNIH-11061401 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adolescents and young adults, aged 12-20, who are hospitalized for anorexia nervosa, including those with "atypical" anorexia nervosa.

Less likely to help

Patients who are not hospitalized for anorexia nervosa or who fall outside the 12-20 age range may not directly benefit from this specific refeeding approach.

What this research studies

Anorexia nervosa often requires hospitalization for nutritional rehabilitation, known as refeeding, but current methods can lead to long stays and frequent readmissions. Our previous work found that a higher-calorie refeeding approach helped patients achieve medical stability sooner without increased risks. This project builds on those findings, further exploring and refining refeeding strategies. We are particularly interested in understanding how these approaches work for patients with "atypical" anorexia nervosa, a growing group who may not appear underweight. The goal is to develop better ways to help young people overcome this serious eating disorder.

Why it matters

Potential benefit: If successful, this approach could help young people with anorexia nervosa recover more quickly, reduce hospital readmissions, and improve long-term health outcomes.

How similar studies have gone: Previous work and a parent trial (StRONG) have shown that a higher-calorie refeeding approach can lead to earlier medical stability and reduced hospital charges.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Garber, Andrea K — University of California, San Francisco
  • Study coordinator: Garber, Andrea K

Related research

Other NIH-funded projects on the same topics.

  • Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure

    A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.

    NIH research Pennsylvania State Univ Hershey Med Ctr · Hershey, United States · NIH-11635771

  • Shorter antifungal treatment for kids with candidemia

    A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606539

  • Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia

    This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606535

  • Shorter antifungal treatment for kids with candidemia

    A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606531

  • Shorter antifungal treatment for kids with candidemia

    This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606505

  • Shorter antifungal course for kids with candidemia

    A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606502

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.